Severe Mitral Valve Regurgitation Secondary to Fulminant Myocarditis in the Setting of a Lupus Flare.
Jesus RomeroSherif ElkattawyRachel AbboudAbdullah MasoodQirat JawedAna L RomeroHardik A FichadiyaAbdel-Azez Abu-SamakYezin F ShamoonOmar ElkattawyMeherwan JoshiFayez E ShamoonPublished in: Journal of community hospital internal medicine perspectives (2024)
Systemic Lupus Erythematosus represents a chronic autoimmune disorder characterized by multiorgan involvement. Lupus myocarditis is a rare presentation of one of the cardiac complications of lupus with an incidence of 3-9%. It usually presents with non-specific symptoms such as dyspnea, orthopnea, chest pain, pedal edema, fever, diaphoresis, paroxysmal nocturnal dyspnea, nausea, vomiting, or palpitations. Even though endomyocardial biopsy is considered the gold standard diagnostic approach, other non-invasive diagnostic alternatives including cardiac magnetic resonance (CMR) have been studied. Therapeutic interventions may range from high-dose steroids, and IVIG, to the most advanced strategies such as mechanical circulatory support including VenoArterial Extracorporeal Membrane Oxygenation (VA-ECMO), and Impella, among others.
Keyphrases
- extracorporeal membrane oxygenation
- systemic lupus erythematosus
- disease activity
- acute respiratory distress syndrome
- mitral valve
- magnetic resonance
- high dose
- left ventricular
- respiratory failure
- risk factors
- chemotherapy induced
- blood pressure
- rheumatoid arthritis
- atrial fibrillation
- sleep quality
- drug induced
- physical activity
- multiple sclerosis
- aortic valve
- mechanical ventilation
- stem cell transplantation
- magnetic resonance imaging
- intensive care unit
- depressive symptoms
- computed tomography
- sleep apnea
- palliative care
- coronary artery disease
- catheter ablation
- silver nanoparticles